KR890003782A - 세펨 화합물의 수용성 항생 조성물 및 수용성염 - Google Patents
세펨 화합물의 수용성 항생 조성물 및 수용성염 Download PDFInfo
- Publication number
- KR890003782A KR890003782A KR1019880010087A KR880010087A KR890003782A KR 890003782 A KR890003782 A KR 890003782A KR 1019880010087 A KR1019880010087 A KR 1019880010087A KR 880010087 A KR880010087 A KR 880010087A KR 890003782 A KR890003782 A KR 890003782A
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- cepam
- water
- compound
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (18)
- 하기 일반식(Ⅱ)의 세팸 화합물 또는 그의 산부가염의 결정, 및 약제학적으로 허용되는 카본산 염을 함유하는 수용성 항생 조성물.(Ⅱ)상기식에서, R1은 적합한 치환체를 함유할 수 있는 지방족 탄화수소의 잔기이며, R2는 헤테로니오(저급)알킬이다.
- 제 1 항에 있어서, 세팸 화합물이 산부가염의 형태인 수용성 항생 조성물.
- 제 2 항에 있어서, 카본사염에 대한 세팸 화합물의 산부가염의 비가 1:0.5 내지 1:4당량인 수용성 향생 조성물.
- 제 2 항에 있어서, 카본사염에 대한 세팸 화합물의 산부가염의 비가 1:1 내지 1:3당량인 수용성 향생 조성물.
- 제 4 항에 있어서, R1이 저급 알킬 또는 저급 알케닐이고, R2는 1-피리디니오 메틸이며, 약제학적으로 허용되는 카본산염은 알킬리금속 탄산수소염 또는 알칼리 금속 탄산염인 수용성 항생 조성물.
- 제 5 항에 있어서, R1이 알킬 또는 프로필인 수용성 항생 조성물.
- 제 6 항에 있어서, 세팸 화합물의 산부 가염이 7-[2-알릴옥시이미노-2-(5-아미노-1,2,4-티아디아졸-3-일)아세트아미도]-3-(1-피리디니오)메틸-3-세팸-4-카복실레이트 염산염(신 이성체)또는 그의 이수화물인 수용성 항생 조성물.
- 제 7 항에 있어서, 알칼리 금속 탄산수소염이 탄산수소나트륨이고, 탄산수소나트륨에 대한 세팸 화하물의 산부가염의 비가 1:1 당량인 수용선 항생 조성물.
- 하기 일반식(Ⅱ)의 세팸 화합물 또는 그의 산부가염의 결정, 및 약제학적으로 허용되는 카본산 염을 혼합시킴을 특징으로 하여, 수용성 항생 조성물을 제조하는 방법.(Ⅱ)상기식에서, R1및 R2는 각각 제 1 항에서 정의한 바와같다.
- 양이온(들) 및 하기 일반식(Ⅱ')의 음이온을 함유하는 염.(Ⅱ')상기식에서, R1은 적합한 치환체를 함유할 수 있는 지방족 탄화수소의 잔기이며, R2는 헤테로니오(저급)알킬이다.
- 제10항에 있어서, 음이온이 하기의 일반식으로 표시하는 염.상기식에서, R1은 저급 알킬 또는 저급 알케닐이고, R2는 1-피리디니오메틸, 퀴누클리디니오메틸 또는 일반식의 그룹이며, 이들은 각각 카바모일을 함유할 수 있다.
- 제11항에 있어서, R2는 1-피리디니오메틸이고, 양이온은 알킬리 금속인 염.
- 제12항에 있어서, 나트륨 7-[2-알릴옥시이미노-2-(5-아미노-1,2,4-티아디아졸-3-일)아세트아미도]-3-(1-피리디니오)메틸-3-세팸-4-카복실레이트 염산염(신 이성체)인 염.
- 제12항에 있어서, 나트륨 7-[2-(5-카복실레이토아미노-1,2,4-티아디아졸-3-일)-2-프로필옥시-이미노아세트아미도]-3-(1-피리디니오)메틸-3-세팸-4-카복실레이트 염산염(신 이성체)인 염.
- 하기 일반식(Ⅱ)의 세팸 화합물 또는 그의 염을, 염기 존재하에 이산화탄소와 반응시키거나 카복산염과 반응시킴을 특징으로하여, 양이온(들) 및 하기 일반식(Ⅱ')의 음이온을 함유하는 염을 제조하는 방법.(Ⅱ)(Ⅱ')상기식에서, R1은 적합한 치환체(들)를 함유할 수 있는 지방족 탄화수소의 잔기이며, R2는 헤테로니오(저급)알킬이다.
- 약제학적으로 허용되는 실제적으로 비독성인 담체 또는 부형제와 함께 제10항의 염을 함유하는 약제학적 조성물.
- 사람 또는 동물에게 제10항의 염을 투여함을 특징으로 하여, 감염성 질환을 치료하는 방법.
- 사람 또는 동물에 있어서 감염성 질환을 치료하기 위한 제10항의 염의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB?8718905? | 1987-08-10 | ||
JP8718905 | 1987-08-10 | ||
GB878718905A GB8718905D0 (en) | 1987-08-10 | 1987-08-10 | Salts of new cephem compounds |
GB878721567A GB8721567D0 (en) | 1987-09-14 | 1987-09-14 | Salts of cephem compounds |
JP8721567 | 1987-09-14 | ||
GB?8721567? | 1987-09-14 | ||
GB?8725051? | 1987-10-26 | ||
JP8725051 | 1987-10-26 | ||
GB878725051A GB8725051D0 (en) | 1987-10-26 | 1987-10-26 | Salts of cephem compounds |
GB878729574A GB8729574D0 (en) | 1987-12-18 | 1987-12-18 | Water-soluble antibiotic composition |
JP8729574 | 1987-12-18 | ||
GB?8729574? | 1987-12-18 | ||
GB?8801423? | 1988-01-22 | ||
GB888801423A GB8801423D0 (en) | 1988-01-22 | 1988-01-22 | Water-soluble antibiotic composition |
JP8801423 | 1988-01-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890003782A true KR890003782A (ko) | 1989-04-18 |
KR970008127B1 KR970008127B1 (ko) | 1997-05-21 |
Family
ID=27516755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880010087A KR970008127B1 (ko) | 1987-08-10 | 1988-08-08 | 세펨 화합물의 수용성 항생 조성물 및 수용성 염, 및 이들의 제조방법 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5104866A (ko) |
EP (1) | EP0303223B1 (ko) |
JP (1) | JP2625937B2 (ko) |
KR (1) | KR970008127B1 (ko) |
AR (1) | AR243380A1 (ko) |
AU (1) | AU616677B2 (ko) |
CA (1) | CA1338780C (ko) |
DE (1) | DE3885031T2 (ko) |
DK (1) | DK445188A (ko) |
ES (1) | ES2059454T3 (ko) |
FI (1) | FI89927C (ko) |
HU (2) | HU210848B (ko) |
IE (1) | IE61679B1 (ko) |
IL (1) | IL87364A0 (ko) |
NO (1) | NO175963C (ko) |
PT (1) | PT88217B (ko) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100572323B1 (ko) | 2003-12-11 | 2006-04-19 | 삼성전자주식회사 | 멀티레벨 고전압 발생장치 |
EP2341053B1 (en) * | 2008-10-31 | 2016-01-13 | Shionogi&Co., Ltd. | Cephalosporin having catechol group |
US9145425B2 (en) | 2010-04-05 | 2015-09-29 | Shionogi & Co., Ltd. | Cephem compound having catechol group |
CN102918047A (zh) * | 2010-04-05 | 2013-02-06 | 盐野义制药株式会社 | 具有假儿茶酚基团的头孢烯类化合物 |
CA2848012A1 (en) | 2011-09-09 | 2013-03-14 | Cubist Pharmaceuticals, Inc. | Methods for treating intrapulmonary infections |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
US9320740B2 (en) | 2013-03-15 | 2016-04-26 | Merck Sharp & Dohme Corp. | Ceftolozane-tazobactam pharmaceutical compositions |
MX2020004205A (es) | 2013-03-15 | 2021-11-16 | Merck Sharp & Dohme Llc | Composiciones antibioticas de ceftolozano. |
AU2014233637A1 (en) | 2013-09-09 | 2015-03-26 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3940483A (en) * | 1971-02-05 | 1976-02-24 | E. R. Squibb & Sons, Inc. | Antibiotic compositions and method |
JPS5329936A (en) * | 1976-08-31 | 1978-03-20 | Takeda Chem Ind Ltd | Antibiotic composition |
US4390534A (en) * | 1978-12-29 | 1983-06-28 | Fujisawa Pharmaceutical Co., Ltd. | Cephem and cepham compounds |
AU536842B2 (en) * | 1978-12-29 | 1984-05-24 | Fujisawa Pharmaceutical Co., Ltd. | Cephalosporin antibiotics |
FR2445833A1 (fr) * | 1979-01-04 | 1980-08-01 | Chimie Biolog | Nouveaux sels d'antibiotiques amines a cycle beta lactame |
US4332800A (en) * | 1979-10-12 | 1982-06-01 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
US4338313A (en) * | 1979-10-12 | 1982-07-06 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
US4563449A (en) * | 1982-07-19 | 1986-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
ES525492A0 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
DE3313818A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
IL77458A (en) * | 1985-01-14 | 1990-07-26 | Eisai Co Ltd | Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor |
DE3706020A1 (de) * | 1987-02-25 | 1988-09-08 | Hoechst Ag | Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
-
1988
- 1988-08-02 IE IE236588A patent/IE61679B1/en not_active IP Right Cessation
- 1988-08-05 IL IL87364A patent/IL87364A0/xx not_active IP Right Cessation
- 1988-08-08 PT PT88217A patent/PT88217B/pt not_active IP Right Cessation
- 1988-08-08 CA CA000574137A patent/CA1338780C/en not_active Expired - Fee Related
- 1988-08-08 KR KR1019880010087A patent/KR970008127B1/ko not_active IP Right Cessation
- 1988-08-09 DE DE88112910T patent/DE3885031T2/de not_active Expired - Fee Related
- 1988-08-09 DK DK445188A patent/DK445188A/da not_active Application Discontinuation
- 1988-08-09 EP EP88112910A patent/EP0303223B1/en not_active Expired - Lifetime
- 1988-08-09 JP JP63199268A patent/JP2625937B2/ja not_active Expired - Lifetime
- 1988-08-09 ES ES88112910T patent/ES2059454T3/es not_active Expired - Lifetime
- 1988-08-09 FI FI883696A patent/FI89927C/fi not_active IP Right Cessation
- 1988-08-09 AR AR88311626A patent/AR243380A1/es active
- 1988-08-09 HU HU884139A patent/HU210848B/hu not_active IP Right Cessation
- 1988-08-09 NO NO883530A patent/NO175963C/no not_active IP Right Cessation
- 1988-08-10 AU AU20598/88A patent/AU616677B2/en not_active Ceased
-
1990
- 1990-07-25 US US07/560,229 patent/US5104866A/en not_active Expired - Lifetime
-
1995
- 1995-06-22 HU HU95P/P00357P patent/HU211940A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
AU616677B2 (en) | 1991-11-07 |
FI89927C (fi) | 1993-12-10 |
EP0303223A2 (en) | 1989-02-15 |
EP0303223B1 (en) | 1993-10-20 |
FI883696A0 (fi) | 1988-08-09 |
HUT47943A (en) | 1989-04-28 |
AR243380A1 (es) | 1993-08-31 |
JPH01110690A (ja) | 1989-04-27 |
JP2625937B2 (ja) | 1997-07-02 |
DE3885031D1 (de) | 1993-11-25 |
AU2059888A (en) | 1989-02-16 |
NO883530L (no) | 1989-02-13 |
CA1338780C (en) | 1996-12-10 |
EP0303223A3 (en) | 1990-11-28 |
DK445188A (da) | 1989-02-11 |
IL87364A0 (en) | 1989-01-31 |
HU210848B (en) | 1995-08-28 |
FI883696A (fi) | 1989-02-11 |
DK445188D0 (da) | 1988-08-09 |
FI89927B (fi) | 1993-08-31 |
PT88217A (pt) | 1989-06-30 |
IE882365L (en) | 1989-02-10 |
KR970008127B1 (ko) | 1997-05-21 |
NO175963C (no) | 1995-01-11 |
NO883530D0 (no) | 1988-08-09 |
DE3885031T2 (de) | 1994-02-17 |
IE61679B1 (en) | 1994-11-16 |
PT88217B (pt) | 1995-03-01 |
NO175963B (no) | 1994-10-03 |
ES2059454T3 (es) | 1994-11-16 |
HU211940A9 (en) | 1996-01-29 |
US5104866A (en) | 1992-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5557572A (en) | Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing it | |
KR940005636A (ko) | 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 수화물 결정 및 이들의 제조방법 | |
KR890003782A (ko) | 세펨 화합물의 수용성 항생 조성물 및 수용성염 | |
US4241057A (en) | Antibiotic compositions | |
NZ203436A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
KR890005124A (ko) | 세펨 화합물 및 이의 제조방법 | |
FI102964B1 (fi) | Terapeuttisia yhdisteitä | |
DE2964903D1 (en) | 2-lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them | |
HUT66515A (en) | Process for preparing piperidine derivatives and pharmaceutical compositions contg. them as active ingredients | |
US2608507A (en) | Dialkyl sulfamyl benzoic acids | |
EP0134179A3 (en) | Derivatives of 4-phenyl-4-oxo-buten-2-oic acid, their preparation, their use as medicines and compositions containing them | |
PT76872A (fr) | Procede pour preparer nouveau derive de thieno-pyridinone | |
ES8203882A1 (es) | Un procedimiento para la preparacion de 1-(8-quinole- il)-2-pirrolidinona y sus sales de adicion de acido | |
IL71068A0 (en) | N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it | |
KR900014305A (ko) | 소염제로서의 나프탈렌메탄아미노 유도체의 용도 및 이를 함유한 약학 조성물 | |
GB1162247A (en) | Cephalosporanic Acid Derivatives and a Process for the Preparation thereof | |
IL61769A0 (en) | 2-phenylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them | |
KR880012577A (ko) | 티아디아졸 구아니딘 화합물 및 이의 제조방법 | |
KR910015586A (ko) | 신규한 세팔로스포린 화합물과 그의 제조방법 | |
KR890005123A (ko) | 세펨 화합물 및 이의 제조방법 | |
GB1270726A (en) | Substituted chromanes | |
KR850000456A (ko) | 세팔로스포린 에스테르의 제조방법 | |
GB1239968A (en) | Cephalosporins | |
SE8204765L (sv) | 2-(o-karboxifenylamino)-6h-pyrimido(2, 1-b)-kinazolon-6 och deras derivat derav, forfarande for framstellning derav och kompositioner innehallande densamma | |
KR920019801A (ko) | 신규 세 팔로스포린계 항생제 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20000512 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |